Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-6/omega-3 supplementation versus risperidone in autism spectrum disorder
jRCT1091220161Completed
- Sponsor
- main researcher in this study
- Start
- Feb 2014
- Countries
- 1
01
Overview
Open-label trial of Arachidonic acid + Docosahexaenoic acid in Autism Spectrum Disorder (ASD) (2 arms), sponsored by main researcher in this study. Primary endpoints: impaired communication, restricted interests and 1 more. Started Feb 2014; status: completed.
02
Drugs
Arachidonic acid + Docosahexaenoic acid
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on jRCT1091220161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220161.